Impact of Multimorbidity and Polypharmacy on Clinical Outcomes of Elderly Chinese Patients with Atrial Fibrillation — Agnieszka Kotalczyk (2022) | RDL Network
Impact of Multimorbidity and Polypharmacy on Clinical Outcomes of Elderly Chinese Patients with Atrial Fibrillation
Article 2022 en
Authors
AK
Agnieszka Kotalczyk
YG
Yutao Guo
YW
Yutang Wang
Abstract
1 min read
Multimorbidity and polypharmacy were common among elderly AF Chinese patients. Multimorbidity was an independent predictor of adverse clinical outcomes. The use of OAC was safe and significantly improved survival amongst AF patients with multimorbidity and polypharmacy.
Monika Kozieł, Stefan Simović, Nikola Pavlović, Aleksandar Kocijančić, Vilma Paparisto, Ljilja Musić, Elina Trendafilova, Anca Rodica Dan, Zumreta Kušljugić, Gheorghe‐Andrei Dan, Professor Gregory Lip, Tatjana Potpara
Davide Antonio Mei, Marco Proietti, Giulio Francesco Romiti, Tommaso Bucci, Bernadette Corica, Alena Shantsila, Hung‐Fat Tse, Giuseppe Boriani, Tze-Fan Chao, Professor Gregory Lip
Giuseppe Boriani, M Vitolo, Marco Proietti, V L Malavasi, N Bonini, G F Romiti, J F Imberti, L Fauchier, Michael Näbauer, Tatjana Potpara, Gheorghe‐Andrei Dan, Zbigniew Kalarus, Aldo Maggioni, Deirdre A. Lane, G Y H Lip
Discussion(0)
No comments yet. Be the first to comment.